Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 14.10
-0.10 (-0.70%)
At close: Feb 10, 2026
Advent Pharma Market Cap
Advent Pharma has a market cap or net worth of 1.31 billion as of February 12, 2026. Its market cap has decreased by -12.42% in one year.
Market Cap
1.31B
Enterprise Value
1.39B
Revenue
516.48M
Ranking
n/a
PE Ratio
22.80
Stock Price
14.10
Market Cap Chart
Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.31B, a decrease of -60.45%. That is a compound annual growth rate of -11.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.31B | 6.02% |
| Dec 30, 2025 | 1.24B | -20.36% |
| Dec 30, 2024 | 1.56B | -32.93% |
| Dec 28, 2023 | 2.32B | -1.97% |
| Dec 29, 2022 | 2.37B | -0.74% |
| Dec 30, 2021 | 2.38B | 14.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |
| Navana Pharmaceuticals | 6.50B |
| Techno Drugs | 4.18B |
| Ambee Pharmaceuticals | 1.88B |
| Pharma Aids | 1.84B |
| Libra Infusions | 1.60B |
| Silco Pharmaceuticals | 1.47B |